PAR
Click for more information
7.69% 21.0¢ paradigm biopharmaceuticals limited..

Chart, page-2776

  1. Denial
    9,855 Posts.
    lightbulb Created with Sketch. 1269
    clock Created with Sketch.
    23/03/22
    11:00
    Post #: 60362492
    Typical M&A consumes the entity and all it's assets. Clearly DD would be required from all parties involved. Hostile isn't necessary to play book.
    PAR Price at posting: $1.14 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RCE Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
right-arrow Created with Sketch.
NEWS Drilling to kick off at high-priority Bara Creek Prospect, targeting a promising epithermal system near the Bowdens Silver Project
right-arrow Created with Sketch.
NEWS Strong in-fill drill results at Theia deposit bolster plans for resource upgrade, advancing Mandilla's growth potential
right-arrow Created with Sketch.
MTL RC Drilling has commenced at Roberts Hill and Mt Berghaus
right-arrow Created with Sketch.
NEWS Strong operational performance drives third consecutive quarter of cash and bullion growth
right-arrow Created with Sketch.
NEWS High-grade drilling results at Coda North: impressive intercepts and major milestone achieved
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
21.0¢ 		Change
0.015(7.69%) 		Mkt cap ! $73.55M
Open High Low Value Volume
20.5¢ 21.0¢ 20.0¢ $216.0K 1.057M

Buyers (Bids)

No. Vol. Price($)
8 143324 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 44935 3
View Market Depth
Last trade - 16.10pm 10/10/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.